Research Interests
Reproductive outcomes in women with blood disorders.
Selected Grants
Advancing Reproductive Rheumatology through Research Mentoring
ResearchAdvisor · Awarded by National Institutes of Health · 2024 - 2029Duke CTSA (TL1) Year 5
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024Moving the ACR's Reproductive Health Guidelines into Practice
ResearchCollaborator · Awarded by Rheumatology Research Foundation · 2021 - 2024Hemostatic markers in the immediate postpartum period
ResearchPrincipal Investigator · Awarded by Coagulant Therapeutics · 2020 - 2023Preventing venous thromboembolism following cesarean delivery: building evidence to inform practice
ResearchMentor · Awarded by Foundation for Women & Girls with Blood Disorders · 2019 - 2022A Multicenter Study on the Retrospective Safety and Efficacy of Fibrinogen Concentrate (Human) (FCH) for Routine Prophylaxis, Treatment of Bleeding or Surgery in Subjects with Congenital Fibrinogen Deficiency with a Prospective Followup Component
ResearchPrincipal Investigator · Awarded by CSL Behring LLC · 2016 - 2017Thrombosis and Hemostasis Centers Research and Prevention Network
ResearchCo Investigator · Awarded by Centers for Disease Control and Prevention · 2002 - 2013IPA
Public ServicePrincipal Investigator · Awarded by National Institutes of Health · 2011 - 2012Integrated Program for Persons with Hemostatic Disorders
ResearchCo Investigator · Awarded by Centers for Disease Control · 2001 - 2007The Obstetrics and Gynecology Risk Group
ResearchCore Leader · Awarded by Josiah Charles Trent Memorial Foundation · 2004 - 2005CDC Menorrhagia Treatment Study
ResearchCo-Principal Investigator · Awarded by Centers for Disease Control and Prevention · 2004 - 2005CDC PO- IUGR Study
ResearchPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2003 - 2004External Relationships
- Cerus Corporation
- UpToDate, Inc
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.